Embed Size (px)
Citation preview
Reunióna2
Asn
NH 2
COOH
Ser
hLys
Ser
COOH
NH 2
Congreso Latinoamericano deGlicobiología5o
Sociedad Latinoamericana de Glicobiología A.C.
2 - 4 Octubre 2019 CDMX
Biosíntesis, función y aplicación de los carbohidratos/glicanos en la salud
Evento responsable con apropiación social de la ciencia.
SCIENTIFIC PROGRAMME
5th LATIN AMERICAN GLYCOBIOLOGY CONGRESSAND 2nd MEETING OF THE GLYCOSCIENCE IN HEALTH
THEMATIC NETWORK
Pre-meeting course “Fundamentals of Glycobiology”Coordinator: Roberta Salinas Marín, PhD.
Tuesday, October 1
8:00 – 8:30 Registry.
8:30 – 9:30 Glycan chemistry and biology. Roberta Salinas Marín, PhD.
9:30 – 11:00 Pathways of glycosylation. Tania María Villanueva Cabello, MSc.
11:00 – 12:00 Congenital disorders in the synthesis and degradation of glycans. Iván Martínez Duncker, MD, ScD.
12:00 – 12:30 Coffee break
12:30 – 14:00 Viral infections and glycans. Kathya Gutiérrez Huante, MSc.
14:00 – 15:00 Lunch
15:00 – 16:00 O-GlcNAc in diabetes and obesity. Yobana Pérez Cervera, PhD.
16:00 – 17:00 Glycobiology of cancer. Verónica Vallejo Ruiz, PhD.
17:00 – 18:30 Structural Analysis of Glycans. Vanessa Hernández Rodríguez, MS. José Antonio Serrato Pérez, PhD.
Carla Asteggiano, PhD.Edgar Zenteno, MD, PhD.Héctor Mora Montes, PhD.Iván Martínez Duncker, MD, ScD.Roberta Salinas Marín, PhD.Tonatiuh Ramírez Reivich, PhD.Verónica Vallejo Ruiz, PhD.
Organizing Committee
Wednesday, October 28:00 – 8:30 Registry
8:30 – 9:00 Inauguration: Iván Martínez Duncker, MD, ScD.
Presidium:Arturo Edgar Zenteno Galindo, MD, PhD – Organizing committee,Faculty of Medicine, UNAM.
Iván Martínez Duncker Ramírez, MD, ScD – Organizing committee,Cell Dynamics Research Center, UAEM.
Octavio Tonatiuh Ramírez Reivich, PhD – Organizing committee,Institute of Biotechnology, UNAM.
Germán Fajardo Dolci, MD, PhD – Director of the Faculty of Medicine, UNAM.
Marion Selosse – Embassy of France in Mexico.
9:00 – 10:00 Opening Conference: Surprises from patients with Congenital Disorders of Glycosylation. Hudson Freeze, PhD. Sanford Children's Health Research Center. USA. Sanford Burnham Prebys Medical Discovery Institute. USA.
10:00 – 10:30 Coffee break
10:30 – 11:10 Muscle deficit associated with Congenital Disorders of Glycosylation (CDG). Carla Asteggiano, PhD. Centro de Estudio de las Metabolopatías Congénitas. Argentina.
11:10 – 11:50 Mucopolysaccharidosis: The clinical experience in the northeast of Mexico. Luz María Sánchez Sánchez, MD. Hospital Regional de Especialidades 25, IMSS. Mexico.
11:50 – 12:30 Application of genomic technologies in genetic diagnosis. Carmen Alaez Verson, PhD. Instituto Nacional De Medicina Genómica. Mexico.
Hereditary metabolic diseasesChair: Iván Martínez Duncker Ramírez, MD, ScD.
12:30 – 13:30 Selected oral presentations
12:30 – 12:35 Flavivirus NS1s, glycans and endothelial cells: finding the sweet spot for viral pathogenesis and disease. Henry Puerta Guardo. Universidad Autónoma de Yucatán. Mexico.
12:35 – 12:40 Comparative biochemical analysis from nucleoside diphosphatases (GDPase/UDPase) from Candida albicans and Candida parapsilosis. Jaime Alberto Bibian García. Universidad de Guanajuato. Mexico.
12:40 – 12:45 Analysis of the cell wall peptidorhamnomannan during the interaction of Sporothrix schenckii with the host. Laura Cristina García Carnero. Universidad de Guanajuato. Mexico.
12:45 – 12:50 Role of the KEX2 protease in the composition of the cell wall and inmune recognition of Candida albicans. Manuela Gómez Gaviria. Universidad de Guanajuato. Mexico.
12:50 – 12:55 Molecular study of L-rhamnose synthesis in Sporothrix schenckii sensu stricto. Alma Karina Tamez Castrellon. Universidad de Guanajuato. Mexico. 12:55 – 13:00 Human adenovirus type 5 E1A increases alpha 1-2 fucosylation and FUT1 and FUT2 expression in infected cells. Kathya Gutiérrez Huante. Universidad Autónoma del Estado de Morelos. Mexico.
13:00 – 13:05 Determination of neuraminidase activity in human macrophages during in vitro infection with dengue virus 2. Javier Serrato Salas. Universidad Autónoma del Estado de Morelos. Mexico.
13:05 – 13:10 Bacterial agglutination activity of glycosylated amino sugar-binding lectin domain of PIRABvp toxin from Vibrio parahaemolyticus. Marcelo Victorio De Los Santos. Centro de Investigación en Alimentación y Desarrollo, A.C. Mexico.
Cancer and immunologyChair: Verónica Vallejo Ruiz, PhD.
Thursday, October 3
8:20 – 9:00 Role of O-GlcNAc glycosylation in inflammatory processes in macrophage. Tarik Issad, PhD. Institut Cochin. France.
9:00 – 9:40 Exploring the pleiotropic roles of O-GlcNAc transferase from the inside to the outside of the cell. Anne-Sophie Vercoutter-Edouart, PhD. Université de Lille. France.
9:40 – 10:20 Expression changes of Galectin-4 and Galectin-9 in cervical cancer. Verónica Vallejo Ruiz, PhD. CIBIOR, Instituto Mexicano del Seguro Social. Mexico.
10:20 – 10:50 Coffee break
10:50 – 11:30 Selected oral presentations
10:50 – 10:55 Expression of sialic acid in MCF-7 cells stimulated with LPS. Brenda Leticia Santiago Olivera. Universidad Autónoma Benito Juárez de Oaxaca. Mexico.
11:35 – 11:40 Selective oxidation of N-Glycolylneuraminic acid using an engineered galactose oxidase. Juana Elizabeth Reyes Martínez. Universidad de Guanajuato. Mexico.
11:40 – 12:20 O-GlcNAcylation of Thymidylate Synthase: a new regulatory mechanism mediating 5-fluorouracil chemotherapy response in colorectal cancer. Ninon Very, PhD. Université de Lille. France.
12:20 – 13:00 O-GlcNAcylation is involved in the regulation of stem cell markers expression in colon cancer cells. Martha Robles Flores, PhD. Universidad Nacional Autónoma de México. Mexico.
13:00 – 13:40 Identification of novel glycoconjugates (glycolipids / polysalic acid) in T lymphocytes. Iván Martínez Duncker Ramírez, MD, ScD. Universidad Autónoma del Estado de Morelos. Mexico.
13:40 – 15:00 Lunch
15:00 – 15:40 Galectins are associated with the neuroinflammation response in neurodegenerative diseases. Daniel Limón Pérez de León, PhD. Benemérita Universidad Autónoma de Puebla. Mexico.
15:40 – 16:20 Heparan sulfate proteoglycans. Patricia Albanese, PhD. Université Paris-Est Créteil Val de Marne. France.
16:20 – 17:00 Alzheimer’s disease and blindness. Luis Hernández Zimbron, PhD. Asociación para Evitar la Ceguera en México. Mexico. Universidad Nacional Autónoma de México. Mexico. 17:00 – 18:00 Poster Session 2
13:10 – 15:00 Lunch
15:00 – 17:00 Social appropriation of science for patients and their families. Support networks. José de Jesús Navarro Torres, MD. Organización Mexicana de Enfermedades Raras. Mexico.
The importance of primary care in rare diseases. Griselda Rodríguez, Social worker. Organización Mexicana de Enfermedades Raras. Mexico.
17:00 – 18:00 Poster Session 1
9:00 – 9:40 Fructans and fructooligosaccharide (FOS) synthesis with Bacillus subtillis levansucrase: mechanism and applications. Agustín López Munguía, PhD. Universidad Nacional Autónoma de México. Mexico.
9.40 – 10:20 Recombinant O‐glycoantingens production from Mycobacterium tuberculosis in Pichia pastoris as a tool to study tuberculosis infection. Norma Adriana Valdez Cruz, PhD. Universidad Nacional Autónoma de México. Mexico.
10:20 – 11:00 Enzymatic synthesis of fucosylated lactose to mimic human milk oligosaccharides. José Mariano García Garibay, PhD. Universidad Autónoma Metropolitana. Mexico.
11:00 – 11:30 Coffee break
11:30 – 12:10 Crucial role of N-glycans in protecting the vaccine candidate E2CD154 against the classical swine fever virus. Gleysin Cabrera Herrera, PhD. Centro de Ingeniería Genética y Biotecnología. Cuba.
12:10– 12:50 Aloe vera – from medicinal plant to an emergent source of bioactive polysaccharides. José Rafael Minjares-Fuentes Universidad Juárez del Estado de Durango, Mexico.
12:50 – 14:40 Lunch
14:40 – 15:20 Protein glycosylation in medically relevant fungi. Héctor Manuel Mora Montes, PhD. Universidad de Guanajuato. Mexico.
10:55 – 11:00 Expression of TF antigen and GALNT in MCF-7 cells stimulated with LPS. Luis Miguel García Cruz. Universidad Autónoma Benito Juárez de Oaxaca. Mexico.
11.00 – 11:05 Selective detection of aberrant N-glycans associated to carcinomas through a Phaseolus vulgaris leucoaglutinin biosensor. Cinthia Ramírez Martínez. Universidad Autónoma del Estado de Hidalgo. Mexico.
11:05 – 11:10 Lactosylated albumin nanoparticles: potential drug nanovehicles with selective targeting toward an in vitro model of hepatocellular carcinoma. Nayelli Guadalupe Terán Saavedra. Universidad de Sonora. Mexico.
11:10 – 11:15 Specific capturing of glycosylated graphene oxide by asialoglycoprotein receptor: a strategic approach for liver targeting. Kevin Ricardo Díaz Gálvez. Universidad de Sonora. Mexico.
11:15 – 11:20 The altered expression of Siglecs profile by monocytes and neutrophils in patients with type 2 diabetes (T2D), as a possible mechanism of immune response impairment. Miguel Esparza Armenta. Universidad de Guanajuato. Mexico.
11:20 – 11:25 Glucosamine protects against hydrogen peroxide in HMEC-1 cells. Berenice Fernández Rojas. Universidad Autónoma Benito Juárez de Oaxaca. Mexico.
11:25 – 11:30 Production of an chitosanase from Aspergillus kawachii to obtain hydrolyzed chitosan. Carlos Neftalí Cano González. Universidad Autónoma de Coahuila. Mexico.
11:30 – 11:35 O-GlcNacylation in dental pulp's stem cells: a potential clinical application. María Cristina Franco Arellanes. Universidad Autónoma Benito Juárez de Oaxaca. Mexico.
8:00 – 8:30 Registry.
8:30 – 9:30 Glycan chemistry and biology. Roberta Salinas Marín, PhD.
9:30 – 11:00 Pathways of glycosylation. Tania María Villanueva Cabello, MSc.
11:00 – 12:00 Congenital disorders in the synthesis and degradation of glycans. Iván Martínez Duncker, MD, ScD.
12:00 – 12:30 Coffee break
12:30 – 14:00 Viral infections and glycans. Kathya Gutiérrez Huante, MSc.
14:00 – 15:00 Lunch
15:00 – 16:00 O-GlcNAc in diabetes and obesity. Yobana Pérez Cervera, PhD.
16:00 – 17:00 Glycobiology of cancer. Verónica Vallejo Ruiz, PhD.
17:00 – 18:30 Structural Analysis of Glycans. Vanessa Hernández Rodríguez, MS. José Antonio Serrato Pérez, PhD.
11:35 – 11:40 Selective oxidation of N-Glycolylneuraminic acid using an engineered galactose oxidase. Juana Elizabeth Reyes Martínez. Universidad de Guanajuato. Mexico.
11:40 – 12:20 O-GlcNAcylation of Thymidylate Synthase: a new regulatory mechanism mediating 5-fluorouracil chemotherapy response in colorectal cancer. Ninon Very, PhD. Université de Lille. France.
12:20 – 13:00 O-GlcNAcylation is involved in the regulation of stem cell markers expression in colon cancer cells. Martha Robles Flores, PhD. Universidad Nacional Autónoma de México. Mexico.
13:00 – 13:40 Identification of novel glycoconjugates (glycolipids / polysalic acid) in T lymphocytes. Iván Martínez Duncker Ramírez, MD, ScD. Universidad Autónoma del Estado de Morelos. Mexico.
13:40 – 15:00 Lunch
15:00 – 15:40 Galectins are associated with the neuroinflammation response in neurodegenerative diseases. Daniel Limón Pérez de León, PhD. Benemérita Universidad Autónoma de Puebla. Mexico.
15:40 – 16:20 Heparan sulfate proteoglycans. Patricia Albanese, PhD. Université Paris-Est Créteil Val de Marne. France.
16:20 – 17:00 Alzheimer’s disease and blindness. Luis Hernández Zimbron, PhD. Asociación para Evitar la Ceguera en México. Mexico. Universidad Nacional Autónoma de México. Mexico. 17:00 – 18:00 Poster Session 2
Neurodegenerative diseasesChair Edgar Zenteno Galindo, MD, PhD.
8:00 – 8:30 Registry
8:30 – 9:00 Inauguration: Iván Martínez Duncker, MD, ScD.
Presidium:Arturo Edgar Zenteno Galindo, MD, PhD – Organizing committee,Faculty of Medicine, UNAM.
Iván Martínez Duncker Ramírez, MD, ScD – Organizing committee,Cell Dynamics Research Center, UAEM.
Octavio Tonatiuh Ramírez Reivich, PhD – Organizing committee,Institute of Biotechnology, UNAM.
Germán Fajardo Dolci, MD, PhD – Director of the Faculty of Medicine, UNAM.
Marion Selosse – Embassy of France in Mexico.
9:00 – 10:00 Opening Conference: Surprises from patients with Congenital Disorders of Glycosylation. Hudson Freeze, PhD. Sanford Children's Health Research Center. USA. Sanford Burnham Prebys Medical Discovery Institute. USA.
10:00 – 10:30 Coffee break
10:30 – 11:10 Muscle deficit associated with Congenital Disorders of Glycosylation (CDG). Carla Asteggiano, PhD. Centro de Estudio de las Metabolopatías Congénitas. Argentina.
11:10 – 11:50 Mucopolysaccharidosis: The clinical experience in the northeast of Mexico. Luz María Sánchez Sánchez, MD. Hospital Regional de Especialidades 25, IMSS. Mexico.
11:50 – 12:30 Application of genomic technologies in genetic diagnosis. Carmen Alaez Verson, PhD. Instituto Nacional De Medicina Genómica. Mexico.
Friday, October 4
9:00 – 9:40 Fructans and fructooligosaccharide (FOS) synthesis with Bacillus subtillis levansucrase: mechanism and applications. Agustín López Munguía, PhD. Universidad Nacional Autónoma de México. Mexico.
9.40 – 10:20 Recombinant O‐glycoantingens production from Mycobacterium tuberculosis in Pichia pastoris as a tool to study tuberculosis infection. Norma Adriana Valdez Cruz, PhD. Universidad Nacional Autónoma de México. Mexico.
10:20 – 11:00 Enzymatic synthesis of fucosylated lactose to mimic human milk oligosaccharides. José Mariano García Garibay, PhD. Universidad Autónoma Metropolitana. Mexico.
11:00 – 11:30 Coffee break
11:30 – 12:10 Crucial role of N-glycans in protecting the vaccine candidate E2CD154 against the classical swine fever virus. Gleysin Cabrera Herrera, PhD. Centro de Ingeniería Genética y Biotecnología. Cuba.
12:10– 12:50 Aloe vera – from medicinal plant to an emergent source of bioactive polysaccharides. José Rafael Minjares-Fuentes Universidad Juárez del Estado de Durango, Mexico.
12:50 – 14:40 Lunch
14:40 – 15:20 Protein glycosylation in medically relevant fungi. Héctor Manuel Mora Montes, PhD. Universidad de Guanajuato. Mexico.
Biotechnology and foodChair: Octavio Tonatiuh Ramírez Reivich, PhD.
Pathogens and infectious diseasesChair: Héctor Manuel Mora Montes, PhD.
15:20 – 16:00 The search for a cryptic L-rhamnosyl transferase on the Sporothrix schenckii genome: probabilistic models of diverging domains. Jorge Humberto Ramírez Prado, PhD. Centro de Investigación Científica de Yucatán. Mexico.
16:00 – 17:00 Closing Conference: Galectin-glycan interactions in viral infection: The good, the bad, and the ugly… Gerardo Vasta, PhD. University of Maryland. USA.
